ctrl K

Price Alert

VistaGen Therapeutics Inc... (VTGN)

NASDAQ: VTGN · Real-Time Price · USD

3.40

0.09 (2.87%)

At close: Aug 18, 2025, 3:59 PM

3.48

2.35%

Pre-market: Aug 19, 2025, 08:08 AM EDT

VistaGen Therapeutics Income Statement

Financials in USD. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Revenue	486K	1.06M	-227K	1.11M	1.09M
Cost of Revenue	n/a	n/a	n/a	815.2K	n/a
Gross Profit	486K	1.06M	-227K	1.11M	1.09M
Operating Income	-55.97M	-33.02M	-59.27M	-47.78M	-17.93M
Interest Income	4.56M	3.35M	49K	20K	15K
Pretax Income	-51.41M	-29.36M	-59.24M	-47.76M	-17.93M
Net Income	-51.42M	-29.36M	-59.25M	-47.76M	-17.93M
Selling & General & Admin	17.08M	14.06M	14.66M	13.25M	7.1M
Research & Development	39.38M	20.02M	44.38M	35.41M	11.93M
Other Expenses	-635K	n/a	n/a	232K	-400
Operating Expenses	55.82M	34.09M	59.04M	48.89M	19.02M
Interest Expense	n/a	n/a	23K	n/a	13K
Selling & Marketing Expenses	n/a	n/a	n/a	2.8M	n/a
Cost & Expenses	56.46M	34.09M	59.04M	48.89M	19.02M
Income Tax Expense	7K	4K	6K	3.4K	2.6K
Shares Outstanding (Basic)	30.71M	19.35M	6.96M	6.6M	2.87M
Shares Outstanding (Diluted)	30.71M	19.35M	6.96M	6.6M	2.87M
EPS (Basic)	-1.67	-1.52	-8.51	-7.38	-14.74
EPS (Diluted)	-1.67	-1.52	-8.51	-7.38	-14.74
EBITDA	-55.34M	-32.45M	-58.74M	-47.05M	-17.44M
EBIT	-55.97M	-33.02M	-59.27M	-47.76M	-17.92M
Depreciation & Amortization	635K	568K	532K	711.1K	477.6K